Bausch Health Companies Inc. (BHC): Total Liabilities
$25.99B
As of 2025-12-31
$25.60B
As of 2026-06-30
+0.7%
3-year compound annual growth
-3.2%
5-year compound annual growth
-4.9%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $25.99B | -3.2% | 2026-02-19, Balance as of period end |
| 2024-12-31 | $26.84B | -2.1% | 2026-02-19, Balance as of period end |
| 2023-12-31 | $27.43B | +7.9% | 2025-02-20, Balance as of period end |
| 2022-12-31 | $25.43B | -13.0% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $29.24B | -4.4% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $30.59B | -6.5% | 2022-02-23, Balance as of period end |
| 2019-12-31 | $32.73B | +10.3% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $29.68B | -5.9% | 2020-02-19, Balance as of period end |
| 2017-12-31 | $31.55B | -21.6% | 2019-02-20, Balance as of period end |
| 2016-12-31 | $40.27B | -6.2% | 2018-02-28, Balance as of period end |
| 2015-12-31 | $42.94B | +105.4% | 2017-03-01, Balance as of period end |
| 2014-12-31 | $20.90B | -8.1% | 2016-04-29, Balance as of period end |
| 2013-12-31 | $22.74B | +59.8% | 2015-02-25, Balance as of period end |
| 2012-12-31 | $14.23B | +55.1% | 2014-02-28, Balance as of period end |
| 2011-12-31 | $9.18B | +56.0% | 2013-02-28, Balance as of period end |
| 2010-12-31 | $5.88B | +734.7% | 2012-02-29, Balance as of period end |
| 2009-12-31 | $704.92M | n/a | 2011-02-28, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $25.99B | -3.2% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $12.14B | +28.2% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $6.98B | +13.9% |
| Viatris Inc (VTRS) | 2025-12-31 | $22.48B | -1.7% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $9.30B | +10.7% |
| Organon & Co. (OGN) | 2025-12-31 | $12.12B | -4.1% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $32.83B | -2.3% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $3.83B | +47.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.81B | +4.5% |
Compare BHC, ZTS, VRTX, VTRS side by side · Screen every company in Pharmaceutical Preparations ↗